Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder

NCT00050206 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Olanzapine
DRUG: Placebo

Sponsor

Eli Lilly and Company